BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 32407486)

  • 1. In vitro pharmacokinetics/pharmacodynamics modeling and efficacy against systemic candidiasis in Drosophila melanogaster of a bisaryloxypropanamine derivative.
    Dalla Lana DF; Kaminski TFA; Lavorato SN; Merkel S; Zanette RA; da Rosa PD; Staudt KJ; de Araújo BV; da Costa B; Quatrin PM; Bazana LCG; Ferreira FA; Caurio CFB; de Andrade SF; Alves RJ; Fuentefria AM
    Med Mycol; 2021 Jan; 59(1):58-66. PubMed ID: 32407486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro activity of a bis-arylidenecyclo-alkanone against fluconazole-susceptible and -resistant isolates of Candida albicans.
    de Sá NP; de Paula LFJ; Lopes LFF; Cruz LIB; Matos TTS; Lino CI; de Oliveira RB; de Souza-Fagundes EM; Fuchs BB; Mylonakis E; Johann S
    J Glob Antimicrob Resist; 2018 Sep; 14():287-293. PubMed ID: 29715565
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Sampaio ADG; Gontijo AVL; Araujo HM; Koga-Ito CY
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a novel and selective fungicide that targets fungal cell wall to treat dermatomycoses: 1,3-bis(3,4-dichlorophenoxy)propan-2-aminium chloride.
    Flores Dalla Lana D; Neiva Lavorato S; Minussi Giuliani L; Cruz L; Lopes W; Henning Vainstein M; Camargo Fontana I; Rigon Zimmer A; de Araújo Freitas M; de Andrade SF; José Alves R; Meneghello Fuentefria A
    Mycoses; 2020 Feb; 63(2):197-211. PubMed ID: 31657052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies.
    Scorneaux B; Angulo D; Borroto-Esoda K; Ghannoum M; Peel M; Wring S
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans.
    Takahata S; Okutomi T; Ohtsuka K; Hoshiko S; Uchida K; Yamaguchi H
    Med Mycol; 2005 May; 43(3):227-33. PubMed ID: 16010849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris.
    Wurster S; Bandi A; Beyda ND; Albert ND; Raman NM; Raad II; Kontoyiannis DP
    J Antimicrob Chemother; 2019 Jul; 74(7):1904-1910. PubMed ID: 31225606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species.
    Chamilos G; Lionakis MS; Lewis RE; Lopez-Ribot JL; Saville SP; Albert ND; Halder G; Kontoyiannis DP
    J Infect Dis; 2006 Apr; 193(7):1014-22. PubMed ID: 16518764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism-based pharmacokinetic-pharmacodynamic models of in vitro fungistatic and fungicidal effects against Candida albicans.
    Venisse N; Grégoire N; Marliat M; Couet W
    Antimicrob Agents Chemother; 2008 Mar; 52(3):937-43. PubMed ID: 18180347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetrandrine enhances the antifungal activity of fluconazole in a murine model of disseminated candidiasis.
    Shi J; Li S; Gao A; Zhu K; Zhang H
    Phytomedicine; 2018 Jul; 46():21-31. PubMed ID: 30097119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral clioquinol is effective in the treatment of a fly model of Candida systemic infection.
    Pippi B; Merkel S; Staudt KJ; Teixeira ML; de Araújo BV; Zanette RA; Andrade SF; Fuentefria AM
    Mycoses; 2019 May; 62(5):475-481. PubMed ID: 30600560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo antifungal activities of aminopiperidine derivatives, novel ergosterol synthesis inhibitors.
    Hata M; Yoshida K; Ishii C; Otani T; Ando A
    Biol Pharm Bull; 2010; 33(3):473-6. PubMed ID: 20190412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal activities of R-135853, a sordarin derivative, in experimental candidiasis in mice.
    Kamai Y; Kakuta M; Shibayama T; Fukuoka T; Kuwahara S
    Antimicrob Agents Chemother; 2005 Jan; 49(1):52-6. PubMed ID: 15616275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
    Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.
    Bozó A; Domán M; Majoros L; Kardos G; Varga I; Kovács R
    J Microbiol; 2016 Nov; 54(11):753-760. PubMed ID: 27796932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fungicidal Potency and Mechanisms of θ-Defensins against Multidrug-Resistant Candida Species.
    Basso V; Garcia A; Tran DQ; Schaal JB; Tran P; Ngole D; Aqeel Y; Tongaonkar P; Ouellette AJ; Selsted ME
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between efficacy of allicin and fluconazole against Candida albicans in vitro and in a systemic candidiasis mouse model.
    Khodavandi A; Alizadeh F; Harmal NS; Sidik SM; Othman F; Sekawi Z; Jahromi MA; Ng KP; Chong PP
    FEMS Microbiol Lett; 2011 Feb; 315(2):87-93. PubMed ID: 21204918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong synergism of dexamethasone in combination with fluconazole against resistant Candida albicans mediated by inhibiting drug efflux and reducing virulence.
    Sun W; Wang D; Yu C; Huang X; Li X; Sun S
    Int J Antimicrob Agents; 2017 Sep; 50(3):399-405. PubMed ID: 28673609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeic acid phenethyl ester synergistically enhances the antifungal activity of fluconazole against resistant Candida albicans.
    Sun L; Liao K; Hang C
    Phytomedicine; 2018 Feb; 40():55-58. PubMed ID: 29496175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing Susceptibility of Drug-Resistant
    Sharafutdinov IS; Ozhegov GD; Sabirova AE; Novikova VV; Lisovskaya SA; Khabibrakhmanova AM; Kurbangalieva AR; Bogachev MI; Kayumov AR
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32024254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.